Plasma neuropeptides in patients undergoing lumbar discectomy

Spine

Volumn 32, Issue 2, 2007, Pages

  Takeuchi, Hirohito ^a   Kawaguchi, Satoshi ^a   Ohwada, Osamu ^b   Kobayashi, Hiroji ^b   Hayakawa, Mitsuru ^b   Takebayashi, Tsuneo ^a   Torigoe, Toshihiko ^a   Sato, Noriyuki ^a   Yamashita, Toshihiko ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Sapporo Minami Orthopedic Hospital   (Japan)

Author keywords

Calcitonin gene related peptide (CGRP); Discectomy; Enzyme linked immunosorbent assay (ELISA); Galanin; Lumbar disc herniation; Neuropeptide; Pain assessment

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; GALANIN; NEUROPEPTIDE; NEUROPEPTIDE Y; SUBSTANCE P;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTERVERTEBRAL DISKECTOMY; LUMBAR DISK; LUMBAR DISK HERNIA; MALE; PEPTIDE ANALYSIS; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEX RATIO; STATISTICAL ANALYSIS; SYMPTOM;

ADOLESCENT; ADULT; AGED; CALCITONIN GENE-RELATED PEPTIDE; DISKECTOMY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALANIN; HUMANS; INTERVERTEBRAL DISK DISPLACEMENT; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; NEUROPEPTIDE Y; NEUROPEPTIDES; PAIN MEASUREMENT; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PROSPECTIVE STUDIES; SCIATICA; SUBSTANCE P;

EID: 33846243742     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/01.brs.0000252204.88750.cf     Document Type: Article

References (30)

1. Grafin SR, Rydevik B, Lind B, et al. Spinal nerve root compression. Spine 1995;20:1810-20.
2. Martin MD, Boxell CM, Malone DG. Pathophysiology of lumbar disc degeneration: a review of the literature. Neurosurg Focus 2002;13:E1.
3. Millan MJ. The induction of pain: an integrative review. Prog Neurobiol 1999;57:1-164.
4. Millan MJ. Descending control of pain. Prog Neurobiol 2002;66:355-474.
5. Nassel DR. Neuropeptides in the nervous system of Drosophila and other insects: multiple roles as neuromodulators and neurohormones. Prog Neurobiol 2002;68:1-84.
6. Schaible H-G, Del Rosso A, Matucci-Cerinic M. Neurogenic aspects of inflammation. Rheum Dis Clin North Am 2005;31:77-101.
7. Hunt SP, Mantyh PW. The molecular dynamics of pain control. Nat Rev Neurosci 2001;2:83-91.
8. Edvinsson L, Udddman R. Neurobiology in primary headaches. Brain Res Rev 2005;48:438-56.
9. Weinstein J. Report of the 1985 ISSLS Traveling Fellowship. Mechanisms of spinal pain: the dorsal root ganglion and its role as a mediator of low-back pain. Spine 1986;11:999-1001.
10. Weinstein J, Pope M, Schmidt R, et al. Neuropharmacologic effects of vibration on the dorsal root ganglion: an animal model. Spine 1988;13:521-5.
11. Kobayashi S, Yoshizawa H, Yamada S. Pathology of lumbar nerve root compression. Part 2: morphological and immunohistochemical changes of dorsal root ganglion. J Orthop Res 2004;22:180-8.
12. Rothman SM, Kreider RA, Winkelstein BA. Spinal neuropeptide responses in persistent and transient pain following cervical nerve root injury. Spine 2005;30:2491-6.
13. Onuoha GN, Alpar EK. Levels of vasodilators (SP, CGRP) and vasoconstrictor (NPY) peptides in early human burns. Eur J Clin Invest 2001;31:253-7.
14. Onuoha GN, Alpar EK. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur. Neuropeptides 2000;34:116-20.
15. Alpar EK, Onuoha G, Killampalli VV, et al. Management of chronic pain in whiplash injury. J Bone Joint Surg Br 2002;84:807-11.
16. Lindh C, Liu Z, Lyrenas S, et al. Elevated cerebrospinal fluid substance P-like immunoreactivity in patients with painful osteoarthritis, but not in patients with rhizopatic pain from a herniated lumbar disc. Scand J Rheumatol 1997;26:468-72.
17. Lindh C, Liu Z, Welin M, et al. Low calcitonin gene-related, peptide-like immunoreactivity in cerebrospinal fluid from chronic pain patients. Neuropeptides 1999;33:517-21.
18. Yamashita T, Kanaya K, Sekine M, et al. A quantitative analysis of sensory function in lumbar radiculopathy using current perception threshold testing. Spine 2002;27:1567-70.
19. Onuoha GN, Alpar EK. Calcitonin gene-related peptide and other neuropeptides in the plasma of patients with soft tissue injury. Life Sci 1999;65:1351-8.
20. Weinstein J, Claverie W, Gibson S. The pain of discography. Spine 1988;13:1344-8.
21. Weinstein J. Neurogenic and nonneurogenic pain and inflammatory mediators. Orthop Clin North Am 1991;22:235-46.
22. Ashina M, Bendtsen L, Jensen R, et al. Plasma levels of calcitonin gene-related peptide in chronic tension-type headache. Neurology 2000;55:1335-40.
23. Landry M, Liu HX, Shi TJ, et al. Galaninergic mechanisms at the spinal level: focus on histochemical phenotyping. Neuropeptides 2005;39:223-31.
24. Ashton IK, Roberts S, Jaffray DC, et al. Neuropeptides in the human intervertebral disc. J Orthop Res 1994;12:186-92.
25. Ghatta S, Nimmagadda D. Calcitonin gene-related peptide: understanding its role. Indian J Pharmacol 2004;36:277-83.
26. Holmes FE, Mahoney SA, Wynick D. Use of genetically engineered transgenic mice to investigate the role of galanin in the peripheral nervous system after injury. Neuropeptides 2005;39:191-9.
27. Kawaguchi S, Yamashita T, Yokogushi K, et al. Immunophenotypic analysis of the inflammatory infiltrates in herniated intervertebral discs. Spine 2001;26:1209-14.
28. Kawaguchi S, Yamashita T, Katahira G, et al. Chemokine profile of herniated intervertebral discs infiltrated with monocytes and macrophages. Spine 2002;27:1511-6.
29. Gronblad M, Virri J, Tolonen J, et al. A controlled immunohistochemical study of inflammatory cells in disc herniation tissue. Spine 1994;19:2744-51.
30. Ito T, Yamada M, Ikuta F, et al. Histologic evidence of absorption of sequestration-type herniated disc. Spine 1996;21:230-4.